Literature DB >> 11091035

Development and persistence of multi-resistance to antibiotics in bacteria; an analysis and a new approach to this urgent problem.

D van der Waaij1, C E Nord.   

Abstract

The intestinal microflora may have more influence on infectious diseases, than the mere control of growth of opportunistic micro-organisms by colonisation resistance (CR) and unspecific stimulation of the immune system. In compromised patients the CR may become decreased for several reasons but mostly because antibiotics reach the intestine during treatment. The consequence of a CR-decrease is that antibiotic-resistant opportunistic micro-organisms may increase in numbers in the gut. In this context, it is hypothesised that if the CR could be maintained at a normal level, the risk for maintenance and spread of resistant strains could be mitigated. Such maintenance requires absence of active antibiotic substance in the gut. This might be brought by the inactivation of antimicrobial agents by intestinal contents. Intra-intestinal inactivation has been described to occur along two possible routes: (1) inactivation by chemical binding or absorption and (2) by enzymatic destruction. Secondly, the composition of the intestinal microflora should be maintained at a normal level in case of other reasons for CR-decrease than antibiotic activity. Comprehensive study of the composition of normal microflora and the strains of species which play a role in CR with techniques which have become available during last decade, is recommended as well as the application of certain pre- and probiotics. It is concluded that antibiotic inactivation may be an ancient strategy of nature which should become incorporated in antibiotic treatment. Antibiotic use and development of resistance may have occurred when ecosystems formed several billions of years ago. Protection against antibiotics produced by newcomers into the ecosystem may have developed as it was necessary to maintain locally available nutrients for the inhabitants of the ecosystem. Should this hypothesis be correct, it is plausible that antimicrobial inactivation by antibiotic inactivating molecules is ubiquitous. In the ecosystem of the digestive tract, molecules involved in inactivation may predominantly be formed by microorganisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091035     DOI: 10.1016/s0924-8579(00)00227-2

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  9 in total

Review 1.  Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance.

Authors:  Fernando Baquero; Teresa M Coque; Fernando de la Cruz
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

2.  Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.

Authors:  Mathias W R Pletz; Mareike Rau; Juergen Bulitta; Andres De Roux; Olaf Burkhardt; Guido Kruse; Michael Kurowski; Carl E Nord; Hartmut Lode
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

3.  Determination of antibacterial and antioxidant potential of some medicinal plants from saurashtra region, India.

Authors:  M Kaneria; Y Baravalia; Y Vaghasiya; S Chanda
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

4.  Production of antimicrobial metabolites against pathogenic bacteria and yeasts by Fusarium oxysporum in submerged culture processes.

Authors:  Liliane Poleto; Letícia Osório da Rosa; Roselei Claudete Fontana; Eliseu Rodrigues; Édina Poletto; Guilherme Baldo; Suelen Paesi; Ceci Sales-Campos; Marli Camassola
Journal:  Bioprocess Biosyst Eng       Date:  2021-03-01       Impact factor: 3.210

5.  Functional metagenomic investigations of the human intestinal microbiota.

Authors:  Aimee M Moore; Christian Munck; Morten O A Sommer; Gautam Dantas
Journal:  Front Microbiol       Date:  2011-10-17       Impact factor: 5.640

Review 6.  Veterinary Medicine Needs New Green Antimicrobial Drugs.

Authors:  Pierre-Louis Toutain; Aude A Ferran; Alain Bousquet-Melou; Ludovic Pelligand; Peter Lees
Journal:  Front Microbiol       Date:  2016-08-03       Impact factor: 5.640

Review 7.  Recent biocontrol measures for fish bacterial diseases, in particular to probiotics, bio-encapsulated vaccines, and phage therapy.

Authors:  Waleed S Soliman; Raafat M Shaapan; Laila A Mohamed; Samira S R Gayed
Journal:  Open Vet J       Date:  2019-07-20

8.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

9.  High-quality genome sequence assembly of R.A73 Enterococcus faecium isolated from freshwater fish mucus.

Authors:  Rim El Jeni; Kais Ghedira; Monia El Bour; Sonia Abdelhak; Alia Benkahla; Balkiss Bouhaouala-Zahar
Journal:  BMC Microbiol       Date:  2020-10-23       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.